January 22, 2021
New insulin molecule can self-adjust according to a patient’s glucose level
Researchers from biotech firm Gubra and the University of Copenhagen, Denmark, created a glucose-responsive insulin molecule that adapts to glucose levels of rats. When blood sugar goes up, the molecule becomes more active and releases more insulin. As blood sugar drops, less...